Legal Advantage Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,891
| Closed | -$237K | – | 95 |
|
|
2025
Q1 | $237K | Hold |
3,891
| – | – | 0.13% | 94 |
|
|
2024
Q4 | $220K | Buy |
+3,891
| New | +$220K | 0.12% | 100 |
|
|
2023
Q4 | – | Sell |
-3,825
| Closed | -$222K | – | 100 |
|
|
2023
Q3 | $222K | Sell |
3,825
-732
| -16% | -$42.5K | 0.16% | 87 |
|
|
2023
Q2 | $291K | Sell |
4,557
-500
| -10% | -$32K | 0.19% | 85 |
|
|
2023
Q1 | $351K | Hold |
5,057
| – | – | 0.26% | 76 |
|
|
2022
Q4 | $364K | Hold |
5,057
| – | – | 0.3% | 71 |
|
|
2022
Q3 | $360K | Buy |
5,057
+459
| +10% | +$32.7K | 0.34% | 64 |
|
|
2022
Q2 | $354K | Hold |
4,598
| – | – | 0.35% | 60 |
|
|
2022
Q1 | $336K | Buy |
4,598
+198
| +5% | +$14.5K | 0.25% | 65 |
|
|
2021
Q4 | $274K | Buy |
+4,400
| New | +$274K | 0.19% | 73 |
|